Future therapeutic approaches for inflammatory bowel diseases.
about
Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn's disease in a Chinese family studyPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorContribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel diseaseBiological treatment of Crohn's disease.Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitisToll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel diseaseAn old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.Induced and natural regulatory T cells in the development of inflammatory bowel disease.Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease.Working out mechanisms of controlled/physiologic inflammation in the GI tract.Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.Ulcerative colitis: prevention of relapse.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.Advances in the medical management of paediatric IBD.Ulcerative colitis: current pharmacotherapy and future directions.Propionyl-L-Carnitine is Efficacious in Ulcerative Colitis Through its Action on the Immune Function and Microvasculature.Assessment of Crohn's disease activity by confocal laser endomicroscopy.Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.Ginsenoside Rh2 alleviates dextran sulfate sodium-induced colitis via augmenting TGFβ signaling.Resveratrol and inflammatory bowel disease: the evidence so far.Cape Gooseberry [Physalis peruviana L.] Calyces Ameliorate TNBS Acid-induced Colitis in Rats.Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice.TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway.
P2860
Q21132010-F5BC6A06-37A7-485D-807D-AA247A0FF4A4Q27022976-6A886BF4-FD73-4A57-8985-509D1C11D999Q27027429-51800377-6556-444C-911C-31888AA3741FQ33354991-114E648A-75EF-4F64-9E43-86C805A64A42Q34269623-F2A1901D-7619-4FA9-9B2E-2D38B8715BFCQ34932421-388CEA81-5F76-44DC-8852-3D39E1195753Q34989162-63A6C146-9595-49BD-A1F2-8AF7CDEA0639Q35420431-C8519BD8-E916-4CA9-A590-5EE8C29D6E87Q35586236-4285269B-3032-4953-9D8E-99928F63609CQ36948341-13F5E33D-7902-43DF-81B7-F15E85EA1072Q37905056-DE584518-9DAE-4E3F-A554-A86766CBADDEQ37947158-D48567FD-BA8C-4FBF-B21E-5C484484BAD7Q37998914-F00E6DA8-0B31-4B06-AAF2-DAADDC715C59Q38049367-9EDF06C2-A6F4-4DD7-8C9B-F4DE31757EDEQ38103628-F1FC4B4A-361F-4ACA-B15E-A659F55D01D3Q38110619-61E19FD4-8671-4E1C-B7E0-6155CC5DD1D5Q38130044-C95838BF-B31A-41F1-BF5B-2C0131FE5C00Q38217653-D5D74CAF-D53A-41AC-AAB2-9A10FDF6A2B0Q38588839-E0F311D5-06A0-49A4-B81B-A538761E8A0CQ39651037-7E0CD874-5803-4D6F-BD10-5C01B359A1D7Q43202907-C2B400BD-16B7-458D-8DDC-377C0CB905C9Q43575032-134C854E-A9AF-438B-97C7-CF01AEAD9937Q46250847-DEB9C790-0F47-42EE-9077-B90815338D51Q46693539-E5985D4E-88A3-42B5-83FB-57F0CA06981CQ49316629-96483B25-161A-4780-8A2D-B5B1002EDE8AQ53024966-B9A29A7B-7285-4D1A-AB15-4B5DB6D063C2
P2860
Future therapeutic approaches for inflammatory bowel diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Future therapeutic approaches for inflammatory bowel diseases.
@en
Future therapeutic approaches for inflammatory bowel diseases.
@nl
type
label
Future therapeutic approaches for inflammatory bowel diseases.
@en
Future therapeutic approaches for inflammatory bowel diseases.
@nl
prefLabel
Future therapeutic approaches for inflammatory bowel diseases.
@en
Future therapeutic approaches for inflammatory bowel diseases.
@nl
P2860
P1433
P1476
Future therapeutic approaches for inflammatory bowel diseases.
@en
P2093
Scott E Plevy
Stephan R Targan
P2860
P304
P356
10.1053/J.GASTRO.2011.02.014
P407
P577
2011-05-01T00:00:00Z